Sentynl Therapeutics Unveils First Clinical Evidence Supporting NULIBRY® for Molybdenum Cofactor Deficiency Type A Sentynl Therapeutics, Inc., a U.S.-based biopharmaceutical company wholly owned by Zydus Lifesciences, Ltd., has announced the publication of groundbreaking clinical data regarding NULIBRY® (fosdenopterin) in the…
Study Finds K Health’s AI Recommendations Match Doctors’ in Accuracy K Health, a leading AI-driven primary care platform, recently revealed exciting results from a novel study demonstrating that its AI-powered Physician Mode closely matched doctors’ clinical decisions in two-thirds of…
U of A Study: Openwater’s Open-LIFU 2.0 Reduces Depression Symptoms in Under 2 Hours Openwater, a leader in open-source medical technology, has announced breakthrough results from a study conducted by the University of Arizona, published in Frontiers in Psychiatry. The…
Viz.ai Wins 2025 Edison Award™ for Machine Learning Innovation for Third Year Viz.ai, a leader in artificial intelligence (AI)-powered disease detection and intelligent care coordination, has announced its recognition as an Award Winner in the 2025 Edison Awards, marking the…
UCI Health Enhances Web Experience with aha! Platform Acquisition Abundant Health Acquisition (aha!) is proud to announce the launch of UCI Health’s newly redesigned website, built on aha!’s Health Experience Platform (HXP). This major update enhances the user experience for…
ABEC Unveils Single-Use Bioreactor for Cell Therapy Manufacturing ABEC, a global leader in engineered solutions for biotechnology manufacturing, has introduced its Advanced Therapy Bioreactor (ATB™), a groundbreaking platform designed to advance the manufacturing of advanced therapy medicinal products (ATMPs). The…
ENHERTU® Approved in the EU for HER2-Low Metastatic Breast Cancer Daiichi Sankyo (TSE: 4568) and AstraZeneca (LSE/STO/Nasdaq: AZN) announced the approval of ENHERTU® (trastuzumab deruxtecan) in the European Union (EU) as a monotherapy for the treatment of adult patients with…
Universal Health Services Releases 2024 Annual Report Universal Health Services (NYSE: UHS), one of the nation’s largest and most respected providers of hospital and healthcare services, has unveiled its 2024 Annual Report, underscoring the company’s significant achievements and commitment to…
GeneDx Expands Exome and Genome Testing to Include Inborn Errors of Immunity GeneDx (Nasdaq: WGS), a leader in genomic diagnostics, has announced the expansion of its commercial focus to include Inborn Errors of Immunity (IEI). IEIs are a group of…
Morris & Dickson Expands 3PL Services with Presa Solutions Acquisition Morris & Dickson Inc., a prominent pharmaceutical wholesaler and specialty distributor, has announced its acquisition of Presa Solutions, a leading virtual third-party logistics (3PL) provider for pharmaceutical manufacturers. This acquisition…
Anaconda Biomed Enrolls First U.S. Patient in ATHENA Trial for ANA Funnel Catheter Anaconda Biomed, S.L., a company focused on developing advanced neuro thrombectomy devices, has announced the enrollment and treatment of the first U.S. patient in its ATHENA clinical…
eClinical Solutions: AI Adoption and Risk-Based Strategies in 2025 Clinical Trials eClinical Solutions LLC, a global provider of digital clinical software and services, has unveiled key insights from its 2025 Industry Outlook, an annual survey of clinical data experts from…